Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veligrotug + Fulvestrant in Advanced Breast Cancer
NCT00774878Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Oct 2008
- Primary completion
- Nov 2010
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of veligrotug in breast cancer, sponsored by Sanofi. Started Oct 2008; status: terminated.
02
Drugs
veligrotug
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00774878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00774878.